XML 65 R49.htm IDEA: XBRL DOCUMENT v3.25.0.1
EQUITY COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Expense Information Based on Fair Value of Stock Options and RSUs
The following table provides compensation expense information based on the fair value of stock options and RSUs for the years ended December 31 as follows:
(In thousands)202420232022
Equity-based Compensation Expense$8,570 $7,198 $6,497 
Tax Benefit(1,564)(1,259)(1,068)
Equity-based Compensation Expense, Net of Tax$7,006 $5,939 $5,429 
Schedule of Weighted Average Fair Value of Options Granted
202420232022
Weighted Average Fair Value of the Options Granted$10.55 $8.39 $5.97 
Schedule of Weighted-Average Assumptions
The weighted average fair value for these options was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions:
202420232022
Risk-free Interest Rate
4.13%
4.20% - 4.33%
3.48% - 3.62%
Dividend Yield
—%
—%
—%
Volatility Factor
0.61
0.58
0.61
Expected Life in Years
7 years
3 - 7 years
5 - 9 years
Schedule of Company's Stock Option Activity and Related Information
A summary of the Company’s stock option activity and related information for the year ended December 31 is as follows:
2024
(Aggregate intrinsic value in thousands)Options
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Outstanding at January 11,410,984 $19.47 $— 
Options Granted75,800 $16.55 $— 
Options Exercised— $— $— 
Options Forfeited / Expired(65,291)$31.35 $— 
Outstanding at December 311,421,493 $18.77 $— 
Exercisable at December 311,084,536 $20.31 $— 
Schedule of Weighted Average Exercise Prices and Contractual Lives for Outstanding and Exercisable Stock Options
The following is a summary of weighted average exercise prices and contractual lives for outstanding and exercisable stock options as of December 31, 2024:
 OutstandingExercisable
Exercise Price RangeShares
Weighted Average
Remaining Life
in Years
Weighted 
Average
Exercise Price
Shares
Weighted Average
Remaining Life
in Years
Weighted
Average
Exercise Price
$9.74 – $16.55
945,850 7.5$12.44 608,894 7.2$11.68 
$22.93 – $35.61
471,079 3.3$31.21 471,078 3.3$31.21 
$45.89 – $45.89
4,564 0.2$45.89 4,564 0.2$45.89 
1,421,493 6.1$18.77 1,084,536 5.5$20.31 
Schedule of RSU Activity
A summary of the Company’s RSU activity and related information for the year ended December 31 is as follows:
2024
RSU Shares
Weighted
Average
Grant Date Fair Value
Unvested at January 1654,160 $11.05 
Granted295,496 $18.91 
Vested(222,138)$16.77 
Forfeited(32,894)$14.61 
Unvested at December 31694,624 $12.39 
Schedule of Fair Value for Options Granted under Employee Stock Purchase Plan
The fair value for the options granted under the Employee Stock Purchase Plan was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions:
202420232022
Risk-free Interest Rate3.96 %5.49 %4.01 %
Dividend Yield— %— %— %
Volatility Factor0.41 0.56 0.50 
Expected Life in Years1.01.01.0